Aurum Biosciences Limited

Aurum Biosciences Ltd, based in Glasgow, UK, is a small holding company with an active status, established 14 years ago in November 2010. The company employs five people and holds £637,113 in assets. With a real address and four directors, it’s a relatively small operation overseen by a single owner. Aurum Biosciences regularly imports machinery, boilers, and mechanical appliances, with parts imported for eight months, the last import occurring in May 2016.

The company’s website highlights its focus on developing novel therapeutics and diagnostics for unmet clinical needs, particularly in areas like Acute Ischemic Stroke (AIS) and Spinal Cord Injury (SCI). Their lead product, ABL101, is an injectable product intended to deliver oxygen beyond clots, potentially protecting tissue and improving treatment options. The website also mentions diagnostics using MRI imaging and the potential for the technology to be applied to inflammation, oncology, and cardiovascular conditions. Aurum Biosciences operates from the Imaging Centre of Excellence at the Queen Elizabeth University Hospital and is clearly aiming to establish itself as a biotechnology innovator.

Financially, Aurum Biosciences presents a mixed picture. While cash reserves increased by a significant 110% to £550,000, current assets only rose by 55% to £640,000. Debtor values decreased by 41%, suggesting possible issues with collecting payments. Most notably, equity decreased by 12% to -£2.9 million, a considerable drop that could indicate ongoing investment or losses. Creditors also decreased, which is a positive sign. The company’s small size (meeting two of three conditions for being a small company) allows for agility, but the declining equity warrants closer attention. The company's accounts were audited by Martin Aitken & Co Ltd.

In conclusion, Aurum Biosciences is a small biotech company with a promising focus on innovative therapies, but its financial performance suggests it’s burning through money. The company’s future success hinges on securing funding and demonstrating the efficacy of its ABL101 product.

Registered in Scotland under the registration number SC387903, with a registered address at G51 4LB, Scotland, Glasgow, Imaging Centre Of Excellence Queen Elizabeth University Hospital, Langlands Drive.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.